PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extract demonstrated anticancer properties in N-diethylnitrosamine-induced hepatocellular carcinoma in male Wistar rats [PMID:33152944]
Methanolic leaf extract showed hepatoprotective effects against aflatoxin B1-induced toxicity in rats [PMID:38572889]
Ent-kaurenoids showed selective cytotoxicity for MCF-7 breast cancer cells and PC-3 prostate cancer cells [PMID:8882434]
Alkaloids from aerial parts showed antibacterial activity, with (-)-anonaine and (+)-nornantenine showing good activity [PMID:27984920]
Acetogenins such as senegalene from A. senegalensis exhibit antileishmanial activity [PMID:10229931, PMID:7809207]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 39162778 (2024) — Total Synthesis of Cyclosenegalin A. · ChemistryOpen
- 2.PMID: 8882434 (1996) — Bioactive ent-kaurene diterpenoids from Annona senegalensis. · Journal of natural products
- 3.PMID: 38572889 (2024) — Hepatoprotective effects of leaf extract of Annona senegalensis against aflatoxin B1 toxicity in rats. · The Onderstepoort journal of veterinary research
- 4.PMID: 36205572 (2022) — Ethnomedicinal plants used for treatment of snakebites in Tanzania - a systematic review. · Pharmaceutical biology
- 5.PMID: 37576509 (2023) — Genetic and morphological diversity in populations of Annona senegalensis Pers. occurring in Western (Benin) and Southern (Mozambique) Africa.